PAHC CEO Sells Into Strength Ahead of Today's Print
Phibro Animal Health Corporation reports its Q3 2026 results today, and the most conspicuous signal heading into the print is not a short seller — it's the CEO. Jack Bendheim, who controls 48% of the company, sold…